Groundbreaking Solutions for Cell Analysis
A critical component of the human immune system is the ability to recognize and kill threatening cells. The immune system achieves this by two mechanisms: antibody-dependent cell-mediated cytotoxicity and T cell killing. Both mechanisms begin with the stimulation of immune cell sub-populations, such as natural killer cells or cytotoxic T lymphocytes, which then actively lyse target cells. A key area of study in the field of cell therapy in immuno-oncology is the mechanism for interplay between immune and cancer cells. The IncuCyte® and Intellicyt® platforms deliver groundbreaking solutions for cell analysis at unprecedented speed, depth, and scale.
IncuCyte® Live-Cell Analysis Solutions for Immune Cell Killing
Quantify immune cell-mediated killing of tumor cells directly from the incubator with IncuCyte® Immune Cell Killing Assays, offering:
- Real-time visualization and fully automated analysis
- Direct measurements of tumor cell death and viability
- Generation of relevant measurement in a highly flexible assay format
- Screening suitable mix-and-read 96/384-well assays
Intellicyt® iQue Screener PLUS Solutions for Immune Cell Killing
MultiCyt® kits include optimized reagents that are validated on iQue® Screener PLUS platforms with
- Time-saving, no-wash protocols
- Flexible throughput formats
- Multiplexing capabilities with other MultiCyt kits
Go to MultiCyt 4-Plex Apoptosis Kit